Angion Biomedica Company
Angion Biomedica is a clinical stage organ restoration biopharmaceutical company focused on renal disease.
Headquarters:
Uniondale, New York, United States
Total Funding:
44356452
Founded Date:
1998
Investors Number:
2
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021
Investor Type:
IPO
Technology:
Data-driven Technologies
Employee Number:
11-50
Industry:
Biopharma, Biotechnology, Medical
Last Funding Type:
Post-IPO Equity
Funding Status:
IPO